# Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)

> **NCT06591260** · — · RECRUITING · sponsor: **Scientific Institute San Raffaele** · enrollment: 20 (estimated)

## Conditions studied

- Myocarditis
- Ventricular Arrhythmia
- Inflammatory Cardiomyopathy
- Genetic Predisposition
- Autoimmunity
- Arrhythmia
- Cardiomyopathies
- Immunosuppresion
- Catheter Ablation

## Interventions

- **OTHER:** support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation

## Key facts

- **NCT ID:** NCT06591260
- **Lead sponsor:** Scientific Institute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2013-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06591260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06591260, "Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06591260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*